Ritva Vanninen Selected Research

N- nor- 3- (4'- iodophenyl)tropane- 2- carboxylic acid methyl ester

8/2010	Serotonin-transporter-linked promoter region polymorphism and serotonin transporter binding in drug-naïve patients with major depression.
8/2008	Midbrain serotonin and striatum dopamine transporter binding in double depression: a one-year follow-up study.
2/2007	Reduced midbrain serotonin transporter availability in drug-naïve patients with depression measured by SERT-specific [(123)I] nor-beta-CIT SPECT imaging.
9/2004	Elevated midbrain serotonin transporter availability in mixed mania: a case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ritva Vanninen Research Topics

Disease

11	Stroke (Strokes) 09/2020 - 12/2005
9	Breast Neoplasms (Breast Cancer) 12/2022 - 10/2015
9	Neoplasms (Cancer) 11/2021 - 11/2004
8	Cognitive Dysfunction 01/2021 - 01/2006
8	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2010
7	Dementia (Dementias) 01/2021 - 01/2008
6	Atrophy 01/2022 - 11/2009
4	Cerebral Infarction 09/2020 - 01/2011
4	Ischemic Stroke 09/2020 - 01/2013
4	Aneurysm (Aneurysms) 01/2013 - 02/2003
4	Major Depressive Disorder (Major Depressive Disorders) 08/2010 - 02/2007
3	Infarction (Infarctions) 09/2020 - 11/2009
3	Unverricht-Lundborg Syndrome (Disease, Unverricht) 04/2015 - 01/2011
3	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 04/2015 - 12/2012
3	Seizures (Absence Seizure) 09/2013 - 04/2008
3	Myoclonus (Nocturnal Myoclonus) 09/2013 - 04/2008
3	Pathologic Constriction (Stenosis) 01/2010 - 05/2005
2	Transient Ischemic Attack 09/2020 - 01/2013
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2010
2	Lymphatic Metastasis 01/2020 - 01/2020
2	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 09/2017
2	Thrombosis (Thrombus) 01/2016 - 02/2003
2	Brain Ischemia (Cerebral Ischemia) 01/2016 - 10/2013
2	Epilepsy (Aura) 10/2015 - 12/2010
2	Myocardial Infarction 01/2015 - 01/2013
2	Hypertension (High Blood Pressure) 01/2015 - 09/2010
2	Carotid Stenosis (Carotid Artery Stenosis) 01/2010 - 11/2005
2	Intracranial Aneurysm (Cerebral Aneurysm) 04/2005 - 02/2003
2	Glioma (Gliomas) 11/2004 - 11/2002
1	Obstructive Sleep Apnea 01/2021
1	Periodontitis 09/2020
1	Inflammation (Inflammations) 09/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2020
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2020
1	Frontotemporal Dementia (Semantic Dementia) 01/2020
1	Neurobehavioral Manifestations 01/2020
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 11/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Neoplasm Metastasis (Metastasis) 09/2017
1	Abdominal Pain (Pain, Abdominal) 02/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Cerebral Hemorrhage 01/2016
1	Encephalocele (Encephalocele, Frontal) 10/2015

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
6	Pharmaceutical PreparationsIBA 11/2019 - 04/2008
4	Amyloid (Amyloid Fibrils)IBA 01/2021 - 10/2013
4	Hyaluronic Acid (Hyaluronan)IBA 02/2020 - 10/2015
4	Apolipoproteins E (ApoE)IBA 01/2017 - 01/2006
4	Cystatin BIBA 04/2015 - 01/2011
4	N- nor- 3- (4'- iodophenyl)tropane- 2- carboxylic acid methyl esterIBA 08/2010 - 09/2004
3	Pemetrexed (MTA)FDA Link 12/2021 - 01/2017
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 01/2008
2	Estrogen ReceptorsIBA 01/2020 - 01/2008
2	Cholinergic Agents (Cholinergics)IBA 01/2015 - 11/2011
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2015 - 11/2011
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 08/2010 - 09/2004
2	Dopamine (Intropin)FDA LinkGeneric 06/2009 - 06/2008
2	ApolipoproteinsIBA 01/2008 - 01/2006
2	Ganciclovir (Cytovene)FDA LinkGeneric 11/2004 - 11/2002
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2021
1	Phosphopyruvate Hydratase (Enolase)IBA 09/2020
1	Calcium-Binding ProteinsIBA 09/2020
1	C-Reactive ProteinIBA 09/2020
1	Biological ProductsIBA 01/2020
1	human ERBB2 proteinIBA 01/2020
1	danaparoid (Orgaran)FDA Link 08/2019
1	Hypoxia-Inducible Factor 1IBA 01/2019
1	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2018
1	EnzymesIBA 01/2018
1	Uridine Diphosphate (UDP)IBA 01/2018
1	Uridine Diphosphate Glucuronic Acid (UDP Glucuronic Acid)IBA 01/2018
1	Complement System Proteins (Complement)IBA 01/2018
1	SugarsIBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Uridine Diphosphate SugarsIBA 01/2018
1	AcetylglucosamineIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 09/2017
1	Messenger RNA (mRNA)IBA 09/2017
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2017
1	Urokinase Plasminogen Activator ReceptorsIBA 05/2017
1	antiarrhythmic peptide (AAP)IBA 02/2017
1	Amyloidogenic ProteinsIBA 01/2017
1	von Willebrand FactorIBA 01/2017
1	AntigensIBA 01/2017

Therapy/Procedure

8	Therapeutics 12/2022 - 12/2005
2	Secondary Prevention 01/2015 - 01/2013
2	Transcranial Magnetic Stimulation 01/2011 - 12/2010
2	Radiotherapy 01/2010 - 11/2004
2	Aftercare (After-Treatment) 11/2009 - 08/2002
2	Stents 01/2008 - 02/2003
1	Mammaplasty (Breast Reconstruction) 10/2022
1	Segmental Mastectomy (Lumpectomy) 11/2021
1	Cognitive Training 01/2019
1	General Anesthesia 09/2018
1	Stroke Rehabilitation 01/2018
1	Thrombectomy 01/2016
1	Anterior Temporal Lobectomy 10/2015
1	Drug Therapy (Chemotherapy) 10/2015